GenprexOffering
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
and investor. In his twenties, he founded and developed a company with $40 million ...
The capital raising process completed on March 29th. Listing on the OTCQX is planned.
include American and foreign investors. Bill Flores Director ...